Lisata Therapeutics, Inc.
LSTA
$2.52
-$0.01-0.40%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 21.97M | 25.83M | 31.25M | 35.86M | 38.26M |
Total Receivables | 1.20M | 750.00K | 1.80M | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.71M | 2.03M | 1.53M | 1.84M | 3.72M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 24.89M | 28.62M | 34.58M | 37.69M | 41.98M |
|
|||||
Total Current Assets | 24.89M | 28.62M | 34.58M | 37.69M | 41.98M |
Net Property, Plant & Equipment | 95.00K | 167.00K | 210.00K | 278.00K | 344.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 157.00K | 174.00K | 192.00K | 210.00K | 228.00K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 23.00K | 23.00K | 22.00K | 19.00K | 21.00K |
Total Assets | 25.16M | 28.98M | 35.00M | 38.20M | 42.57M |
|
|||||
Total Accounts Payable | 782.00K | 602.00K | 1.28M | 556.00K | 728.00K |
Total Accrued Expenses | 3.48M | 3.11M | 4.19M | 3.95M | 3.55M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 47.00K | 92.00K | 137.00K | 181.00K | 176.00K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 4.31M | 3.81M | 5.61M | 4.69M | 4.46M |
|
|||||
Total Current Liabilities | 4.31M | 3.81M | 5.61M | 4.69M | 4.46M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | 47.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 72.00K | 72.00K | 72.00K | 72.00K | 72.00K |
Total Liabilities | 4.39M | 3.88M | 5.69M | 4.76M | 4.58M |
|
|||||
Common Stock & APIC | 579.24M | 578.93M | 578.43M | 577.89M | 577.56M |
Retained Earnings | -557.45M | -552.79M | -548.07M | -543.46M | -538.53M |
Treasury Stock & Other | -758.00K | -786.00K | -789.00K | -740.00K | -785.00K |
Total Common Equity | 21.03M | 25.36M | 29.57M | 33.69M | 38.25M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 21.03M | 25.36M | 29.57M | 33.69M | 38.25M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -254.00K | -254.00K | -254.00K | -254.00K | -254.00K |
Total Equity | 20.78M | 25.10M | 29.32M | 33.44M | 38.00M |
|